Glucose, urea, and creatinine laboratory tests in people starting antiretroviral therapy with dolutegravir or efavirenz: a cohort study in Belo Horizonte, Brazil. (2022). Research, Society and Development, 11(5), e43711528541. https://doi.org/10.33448/rsd-v11i5.28541